About J3 Bioscience

J3 Bioscience (J3 Bio) is dedicated to advancing women’s health through innovative, safe, and accessible products. Our lead product, LivRing, is built on J3 Bio’s proprietary, patented intravaginal ring (IVR) platform—an advanced reservoir-based system engineered for sustained, localized delivery of therapeutic ingredients. LivRing provides up to 7 days of controlled release of a lubricating vaginal moisturizer for long-lasting relief from vaginal dryness, discomfort, and painful sex. As the longest acting product available in the category, LivRing provides rapid symptom relief while eliminating the need for daily applications or reapplications. In addition to LivRing, J3 Bio’s IVR technology can accommodate a broad spectrum of ingredients and release profiles, creating a versatile platform to address unmet needs in women’s health.


In the News

J3 Bioscience Appoints Dr. Stephanie Singer as Medical Director

June 24, 2025

Consumers Find LivRing® Effectively Addresses Needs for Vaginal Dryness Relief

May 21, 2025

J3 Bioscience, Inc. Appoints John Fair as New President & CEO

April 3, 2025

Management

John Fair President & CEO

R. Tyler McCabe, PhD Co-Founder, COO

Stephanie Singer, DO, FACOG Medical Director

Board of Directors

Tim S. Glassett, JD, MBA Chairman

John Fair

Stath Karras, MBA

Sheryl Kingsberg, PhD

DJ Lee, MD, PhD

Keith Marmer, DPT, MBA

Troy E. Mason

R. Tyler McCabe, PhD

Ron Nielsen

Stephanie Singer, DO, FACOG